Cen Biotech Inc (CENB) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cen Biotech Inc  (CENB)


Cen Biotech Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cen Biotech Inc's ROI in the third quarter of 2022?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Cen Biotech Inc's return on investment (ROI) in its third quarter of 2022

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -2 -2 -2 -2 -2
Return On Investment (TTM) - - - - -
CENB's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - 110.41 %
Net Income (TTM) in Millions -3 -3 -19 -19 2

CENB Company Profile >> Back to CENB Roi Comparisons >> See Annual CENB Return On Investment



Return On Investment CENB's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Cen Biotech Inc's III. Quarter Investments $ -2 Millions CENB's Balance sheet
Cen Biotech Inc's III. Quarter Income $ 0 Millions Quarterly CENB's Income Statement
CENB's Income by Division See CENB's Income by Division


CENB Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions -2 -8 -24 -17 -11
Y / Y Investment Growth - - - - -
Net Income in Millions 1 14 -6 -8 -14
Y / Y Net Income Growth -95.74 % - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CENB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CENB's Competitors
Subscribers only: Roi for Cen Biotech Inc's Suppliers
Subscribers only: Return On Investment for CENB's Customers

Other Ratios
CENB's Roa CENB's Inventory Turnover Ratio CENB's Growth Rates CENB's Dividend Statistics
CENB's Profitability Ratios CENB's Asset Turnover Ratio CENB's Dividend Growth
CENB's Roe CENB's Valuation Ratios CENB's Financial Strength Ratios CENB's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI
Theravance Biopharma inc   236.71 %
Chimerix Inc   143.78 %
Talphera Inc   97.06 %
Cardiff Lexington Corporation  94.94 %
Vivos Therapeutics Inc   77.62 %
Molecular Templates Inc   75.84 %
Sensus Healthcare Inc   65.09 %
Moderna Inc   65.01 %
Siga Technologies Inc  63.34 %
Omeros Corporation  62.41 %
Kiniksa Pharmaceuticals International Plc  60.29 %
Biomx Inc  59.27 %
Intercept Pharmaceuticals inc   59.07 %
Glucotrack Inc   54.64 %
Vir Biotechnology Inc   53.95 %
Dynavax Technologies Corporation  52.91 %
Oncotelic Therapeutics Inc   48.74 %
Journey Medical Corp  45.06 %
Biofrontera Inc   44.78 %
Idexx Laboratories Inc  41.99 %
REST EZ Inc.  41.68 %
Iteos Therapeutics Inc   40.85 %
Prophase Labs Inc   39.24 %
Mettler toledo International Inc   38.09 %
Orgenesis Inc   37.05 %
Vicarious Surgical Inc  36.26 %

Date modified: 2026-08-30T04:42:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.